+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drugs of Abuse Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5205442
  • Report
  • November 2020
  • Region: Global
  • 85 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Diagnostics
  • Banyan Biomarkers Inc
  • Ceres Nanosciences Inc
  • Horiba Ltd
  • SDI Biomed, Inc.
  • SensoDXII LLC
Summary

The publisher's Medical Devices sector report, “Drugs of Abuse Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Drugs of Abuse Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Drugs of Abuse Tests are used for the detection of illegal and/or prescribed substances in the patient samples including urine, blood, saliva, or sweat.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Drugs of Abuse Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Drugs of Abuse Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Drugs of Abuse Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Diagnostics
  • Banyan Biomarkers Inc
  • Ceres Nanosciences Inc
  • Horiba Ltd
  • SDI Biomed, Inc.
  • SensoDXII LLC
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Drugs of Abuse Overview

3 Products under Development
3.1 Drugs of Abuse - Pipeline Products by Stage of Development
3.2 Drugs of Abuse - Pipeline Products by Territory
3.3 Drugs of Abuse - Pipeline Products by Regulatory Path
3.4 Drugs of Abuse - Pipeline Products by Estimated Approval Date

4 Drugs of Abuse - Pipeline Products under Development by Companies
4.1 Drugs of Abuse Companies - Pipeline Products by Stage of Development
4.2 Drugs of Abuse - Pipeline Products by Stage of Development

5 Drugs of Abuse Companies and Product Overview

6 Drugs of Abuse - Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact

List of Tables
Table 1: Drugs of Abuse - Pipeline Products by Stage of Development
Table 2: Drugs of Abuse - Pipeline Products by Territory
Table 3: Drugs of Abuse - Pipeline Products by Regulatory Path
Table 4: Drugs of Abuse - Pipeline Products by Estimated Approval Date
Table 5: Drugs of Abuse Companies - Pipeline Products by Stage of Development
Table 6: Drugs of Abuse - Pipeline Products by Stage of Development
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Alinity c Assay - Ecstasy - Product Status
Table 9: Alinity c Assay - Ecstasy - Product Description
Table 10: Alinity c Assay - Opiates - Product Status
Table 11: Alinity c Assay - Opiates - Product Description
Table 12: Alinity c Assay - Tricyclic Antidepressants - Product Status
Table 13: Alinity c Assay - Tricyclic Antidepressants - Product Description
Table 14: Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 15: CLIAgen Steroid Assay - Product Status
Table 16: CLIAgen Steroid Assay - Product Description
Table 17: Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Diagnostic Assay - Alcoholism - Product Status
Table 19: Diagnostic Assay - Alcoholism - Product Description
Table 20: BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: ABA-SUBSTANCE - Product Status
Table 22: ABA-SUBSTANCE - Product Description
Table 23: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Nanotrap Fentanyl Assay - Product Status
Table 25: Nanotrap Fentanyl Assay - Product Description
Table 26: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Genedrive - OPRM1 Assay - Product Status
Table 28: Genedrive - OPRM1 Assay - Product Description
Table 29: Horiba Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Pentra C200 Analyzer - DAU Assay - Product Status
Table 31: Pentra C200 Analyzer - DAU Assay - Product Description
Table 32: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: VITROS 4600 System - Fentanyl Assay - Product Status
Table 34: VITROS 4600 System - Fentanyl Assay - Product Description
Table 35: VITROS 4600/5,1 FS Chemistry System - Buprenorphine Assay - Product Status
Table 36: VITROS 4600/5,1 FS Chemistry System - Buprenorphine Assay - Product Description
Table 37: VITROS 4600/5,1 FS Chemistry System - Ethyl Glucronide Assay - Product Status
Table 38: VITROS 4600/5,1 FS Chemistry System - Ethyl Glucronide Assay - Product Description
Table 39: VITROS 4600/5,1 FS Chemistry System - Heroin Metabolite Assay - Product Status
Table 40: VITROS 4600/5,1 FS Chemistry System - Heroin Metabolite Assay - Product Description

List of Figures
Figure 1: Drugs of Abuse - Pipeline Products by Stage of Development
Figure 2: Drugs of Abuse - Pipeline Products by Territory
Figure 3: Drugs of Abuse - Pipeline Products by Regulatory Path
Note: Product cover images may vary from those shown
  • Abbott Diagnostics
  • Adaltis Srl
  • Banyan Biomarkers Inc
  • BioMark Technologies Inc
  • Ceres Nanosciences Inc
  • genedrive plc
  • Horiba Ltd
  • Ortho-Clinical Diagnostics Inc
  • Randox Laboratories Ltd
  • Roche Diagnostics International Ltd
  • SDI Biomed, Inc.
  • Sebia SA
  • SensoDXII LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • University of California San Francisco
Note: Product cover images may vary from those shown
Adroll
adroll